581 related articles for article (PubMed ID: 31128485)
1. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
[TBL] [Abstract][Full Text] [Related]
2. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
3. A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.
Sun L; Fahey P; Zhu X; Ng W; Chen ZP; Qiu Y; Lai H; Lin J; Lin L
Integr Cancer Ther; 2018 Sep; 17(3):902-911. PubMed ID: 29775121
[TBL] [Abstract][Full Text] [Related]
4.
Liu Y; Li Y; Wang X; Huang Y; Zhang Q; Shi K; Ran C; Hou J; Wang X
J Altern Complement Med; 2020 Oct; 26(10):956-965. PubMed ID: 32614605
[No Abstract] [Full Text] [Related]
5. A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow-up.
Sun Z; Liang ST; Zhai XF; Lang QB; Zhou QH; Yue XQ; He J; Xu J; Zhu Y; Ling CQ
J Tradit Chin Med; 2012 Jun; 32(2):156-63. PubMed ID: 22876437
[TBL] [Abstract][Full Text] [Related]
6. Impact of Traditional Chinese Medicine on Prognosis of Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study.
Yuan H; Niu Q; Shang X; Zhang L; Li L; Yang H; Gou C; Li J; Li H; Li X
Integr Cancer Ther; 2023; 22():15347354231170536. PubMed ID: 37395564
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study.
Yan H; Wang X; Yu L; Liu X; Yan F; Xie Y; Pu Q; Yang Z
Front Pharmacol; 2024; 15():1353720. PubMed ID: 38464727
[TBL] [Abstract][Full Text] [Related]
8. Effect of Bushen Jianpi formula on survival of patients with moderate and advanced hepatocellular carcinoma: a retrospective study.
Wang L; Li X; Zhou R; Shan Y
J Tradit Chin Med; 2020 Aug; 40(4):683-689. PubMed ID: 32744036
[TBL] [Abstract][Full Text] [Related]
9. Chinese medicine herbal treatment based on syndrome differentiation improves the overall survival of patients with unresectable hepatocellular carcinoma.
Man YN; Liu XH; Wu XZ
Chin J Integr Med; 2015 Jan; 21(1):49-57. PubMed ID: 25533651
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of hepatectomy combined with Jianpi Huayu Therapy for hepatocellular carcinoma.
Zhong C; Li HD; Liu DY; Xu FB; Wu J; Lin XM; Guo RP
Asian Pac J Cancer Prev; 2014; 15(14):5951-7. PubMed ID: 25081728
[TBL] [Abstract][Full Text] [Related]
11. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
12. Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients.
Chen LY; Zhai XF; Chen Z; Zhu JF; Qian PA; Zhao HT; Ling CQ
Oncotarget; 2017 May; 8(18):30471-30476. PubMed ID: 27791987
[TBL] [Abstract][Full Text] [Related]
13. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
[TBL] [Abstract][Full Text] [Related]
14. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
15. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
Lu HL; Su YC; Lin MC; Sun MF; Huang ST
Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
[TBL] [Abstract][Full Text] [Related]
16. Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study.
Chen HY; Pan HC; Chen YC; Chen YC; Lin YH; Yang SH; Chen JL; Wu HT
BMC Complement Altern Med; 2019 Apr; 19(1):81. PubMed ID: 30943956
[TBL] [Abstract][Full Text] [Related]
17. Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study.
Hou C; Yang D; Zhang Y; Li Y; He Z; Dai X; Lu Q; Wang S; Zhang X; Liu Y
Integr Cancer Ther; 2021; 20():15347354211058464. PubMed ID: 34781754
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis.
Xu H; Wei W; Y M; Dong C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31872855
[TBL] [Abstract][Full Text] [Related]
19. Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study.
Kuo YT; Liao HH; Chiang JH; Wu MY; Chen BC; Chang CM; Yeh MH; Chang TT; Sun MF; Yeh CC; Yen HR
Integr Cancer Ther; 2018 Jun; 17(2):411-422. PubMed ID: 28774207
[TBL] [Abstract][Full Text] [Related]
20. Active Treatments Prolong the Survival in Patients With Hepatocellular Carcinoma and Performance Status 3 or 4: A Propensity Score Analysis.
Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Tsai YJ; Nagaria TS; Lin HC; Huo TI
J Clin Gastroenterol; 2015; 49(10):878-84. PubMed ID: 25710525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
